JP5906252B2 - 歯科疾患、障害、および損傷の治療方法 - Google Patents

歯科疾患、障害、および損傷の治療方法 Download PDF

Info

Publication number
JP5906252B2
JP5906252B2 JP2013544452A JP2013544452A JP5906252B2 JP 5906252 B2 JP5906252 B2 JP 5906252B2 JP 2013544452 A JP2013544452 A JP 2013544452A JP 2013544452 A JP2013544452 A JP 2013544452A JP 5906252 B2 JP5906252 B2 JP 5906252B2
Authority
JP
Japan
Prior art keywords
cells
accs
pharmaceutical composition
composition
timp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013544452A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014501242A (ja
JP2014501242A5 (enExample
Inventor
ゴールデン，ウィリアム，ジェイ．
ラップ，ランダル，ジー．
Original Assignee
ステムニオン，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ステムニオン，インコーポレイテッド filed Critical ステムニオン，インコーポレイテッド
Publication of JP2014501242A publication Critical patent/JP2014501242A/ja
Publication of JP2014501242A5 publication Critical patent/JP2014501242A5/ja
Application granted granted Critical
Publication of JP5906252B2 publication Critical patent/JP5906252B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C17/00—Devices for cleaning, polishing, rinsing or drying teeth, teeth cavities or prostheses; Saliva removers; Dental appliances for receiving spittle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Dentistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP2013544452A 2010-12-20 2011-12-14 歯科疾患、障害、および損傷の治療方法 Active JP5906252B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061459859P 2010-12-20 2010-12-20
US61/459,859 2010-12-20
PCT/US2011/001980 WO2012087348A1 (en) 2010-12-20 2011-12-14 Methods for treating dental diseases, disorders and injuries

Publications (3)

Publication Number Publication Date
JP2014501242A JP2014501242A (ja) 2014-01-20
JP2014501242A5 JP2014501242A5 (enExample) 2014-12-18
JP5906252B2 true JP5906252B2 (ja) 2016-04-20

Family

ID=46234868

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013544452A Active JP5906252B2 (ja) 2010-12-20 2011-12-14 歯科疾患、障害、および損傷の治療方法

Country Status (6)

Country Link
US (2) US20130302262A1 (enExample)
EP (1) EP2654434A4 (enExample)
JP (1) JP5906252B2 (enExample)
CN (1) CN103338643B (enExample)
CA (1) CA2820445A1 (enExample)
WO (1) WO2012087348A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9802010B2 (en) * 2013-11-22 2017-10-31 Noveome Biotherapeutics, Inc. Interproximal drug delivery device
US20150335712A1 (en) 2014-05-21 2015-11-26 Stemnion, Inc. Treatment of Diseases and Conditions Caused by Increased Vascular Permeability
CN109715193A (zh) * 2016-08-16 2019-05-03 克里登蒂斯股份公司 用于治疗牙龈炎、牙周炎和/或种植体周围炎的包含自组装肽的组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1268393A2 (en) 2000-03-20 2003-01-02 Trustees Of Boston University Lipoxin analogs and methods for the treatment of periodontal disease
CA2483010A1 (en) * 2002-04-19 2003-10-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Placental derived stem cells and uses thereof
EP1755537A4 (en) 2004-04-14 2009-12-09 Univ Boston METHOD AND COMPOSITIONS FOR PREVENTING OR TREATING PERIODONTOPATHIA
WO2006071659A1 (en) 2004-12-29 2006-07-06 Trustees Of Boston University Delivery of h2 antagonists
US8153430B2 (en) * 2005-03-31 2012-04-10 Stemnion, Inc. Methods related to surgery
US20060222634A1 (en) * 2005-03-31 2006-10-05 Clarke Diana L Amnion-derived cell compositions, methods of making and uses thereof
WO2007061783A1 (en) 2005-11-18 2007-05-31 Trustees Of Boston University Treatment and prevention of bone loss using resolvins
US8871198B2 (en) * 2006-03-29 2014-10-28 Stemnion, Inc. Methods related to wound healing
JP2008206500A (ja) * 2007-02-28 2008-09-11 Tokyo Univ Of Science 歯の製造方法及びこれにより得られた歯
WO2009014668A2 (en) 2007-07-24 2009-01-29 Stemnion, Inc. Methods for promoting hair growth
JP2010536851A (ja) 2007-08-22 2010-12-02 ステムニオン，インコーポレイテッド 新規の細胞性因子含有溶液組成物
EP2197270B8 (en) * 2007-09-07 2020-03-04 Surgical Biologics, LLC Placental tissue grafts and improved methods of preparing and using the same
EP2665482B1 (en) * 2011-01-18 2017-10-11 Noveome Biotherapeutics, Inc. Wound healing device and method
WO2012112410A2 (en) * 2011-02-14 2012-08-23 Mimedx Group Inc. Micronized placental tissue compositions and methods for making and using the same

Also Published As

Publication number Publication date
US20130302262A1 (en) 2013-11-14
CN103338643B (zh) 2016-02-10
JP2014501242A (ja) 2014-01-20
WO2012087348A1 (en) 2012-06-28
US20120156649A1 (en) 2012-06-21
EP2654434A1 (en) 2013-10-30
CN103338643A (zh) 2013-10-02
US8444417B2 (en) 2013-05-21
CA2820445A1 (en) 2012-06-28
EP2654434A4 (en) 2015-11-04

Similar Documents

Publication Publication Date Title
US8318672B2 (en) Cellular factor-containing solution compositions
JPH11507048A (ja) 変形性関節症治療用デブロモヒメニアルジシン及び関連化合物の使用
CN117899116A (zh) 使用胎盘细胞外基质治疗口腔病变
US20160175365A1 (en) Methods for treating PKU
US8444417B2 (en) Methods for treating dental diseases, disorders, and injuries
US10000738B2 (en) Usage of odontogenic stem cells and genetically modified odontogenic stem cells
US20160324928A1 (en) Methods for treating blepharitis
JP6041812B2 (ja) 結合組織の損傷および障害の治癒を促進する方法
US20220030851A1 (en) Modulating ischemic injury
US8454957B2 (en) Methods for treating coagulation disorders
US20120121547A1 (en) Methods and compositions for treating chronic wounds
JP2024537422A (ja) 子宮内膜組織を治療するための組成物及び方法
US8980251B2 (en) Methods for preventing and treating hemorrhoids
US20110311514A1 (en) Methods for treating disorders of amino acid metabolism

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20140523

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140523

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141031

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20141031

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150825

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151125

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160301

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160318

R150 Certificate of patent or registration of utility model

Ref document number: 5906252

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250